50% off all subscriptions! ... left. Order NowOrder Now

BioMarin Pharmaceutical Inc. Stock Forecast NASDAQ:BMRN

$87.58 (-2.22%)

Volume: 921k

Closed: Nov 26, 2021

Hollow Logo Score: 1.794

BioMarin Pharmaceutical Inc. Stock Forecast

$87.58 (-2.22%)

Volume: 921k

Closed: Nov 26, 2021

Score Hollow Logo 1.794
Which way will BMRN go? Request
Stop-loss: $83.06 (-5.16%)
Key Stats
P/E Ratio 1 010.18
Beta 0.9
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 60 and the stock is currently not being overbought or oversold

Red day on Friday for BioMarin Pharmaceutical Inc.
(Updated on Nov 26, 2021)


Buy or Hold candidate since 2021-10-29 Gain 10.54%

The BioMarin Pharmaceutical Inc. stock price fell by -2.22% on the last day (Friday, 26th Nov 2021) from $89.57 to $87.58. and has now fallen 5 days in a row. During the day the stock fluctuated 4.03% from a day low at $86.26 to a day high of $89.74. The price has fallen in 6 of the last 10 days, but is still up by 7.54% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 thousand shares and in total, 921 thousand shares were bought and sold for approximately $80.66 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.67% during the next 3 months and, with a 90% probability hold a price between $77.52 and $96.99 at the end of this 3-month period.

Signals & Forecast

The BioMarin Pharmaceutical Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $87.48 and $80.44. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 19, 2021, and so far it has fallen -4.25%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $78.20 and $77.98. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioMarin Pharmaceutical Inc. finds support just below today's level at $78.20. If this is broken, then the next support from accumulated volume will be at $77.98 and $77.76.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.48 between high and low, or 4.03%. For the last week, the stock has had a daily average volatility of 4.45%.

Our recommended stop-loss: $83.06 (-5.16%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Is BioMarin Pharmaceutical Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioMarin Pharmaceutical Inc. stock to perform well in the short-term.

Current score: 1.794

Predicted Opening Price for BioMarin Pharmaceutical Inc. of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$87.86 $87.58 (Undervalued)
Buy Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 23, 2021 "Robert W. Baird" gave "$101.00 - $112.00" rating for BMRN. The price target was changed from $90.06 to 0.3%.

Volatility and Risk
Daily Average Volatility: 4.45 %
Overall Risk: Very High High Medium Low Very Low
Volatility
4.45 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $89.79
Price: $87.58
Support: $78.20

BMRN Insider Trading Show all Trades

INSIDER POWER

1.561

Last 100 transactions
Buy: 525 398 | Sell: 336 508 (Shares)
Date Action Amount Person Type
Oct 26, 2021 Sell 2 739 Ajer Jeffrey Robert Common Stock
Oct 20, 2021 Buy 1 000 Bienaime Jean Jacques Common Stock
Oct 20, 2021 Sell 1 000 Bienaime Jean Jacques Stock Option (Right to buy Common Stock)
Aug 02, 2021 Sell 5 518 Davis George Eric Common Stock
Jul 16, 2021 Sell 285 Acosta Andrea Common Stock
Show all Insider Trades
INSIDER POWER

1.561

Last 100 transactions
Buy: 525 398 | Sell: 336 508 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 91.34 4.29 %
90.01 2.78 %
89.19 1.84 %
Current price: 87.58
Support 86.53 -1.20 %
85.71 -2.14 %
84.38 -3.65 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 91.47 4.44 %
90.30 3.11 %
89.79 2.52 %
Current price 87.58
Support 78.20 -10.71%
77.98 -10.96%
77.76 -11.21%

Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Kuvan, a proprietary syn... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT